Literature DB >> 10893646

Plasma levels of cavernous and systemic norepinephrine and epinephrine in men during different phases of penile erection.

A J Becker1, S Uckert, C G Stief, M C Truss, S Machtens, F Scheller, W H Knapp, U Hartmann, U Jonas.   

Abstract

PURPOSE: Knowledge of the functional anatomy, hemodynamics, neurophysiology and pharmacology of penile erection has improved tremendously during the last 2 decades. However, only few in vivo studies on human peripheral neurotransmission have been carried out up until now. Therefore, we conducted a study to examine plasma levels of catecholamines norepinephrine (NE) and epinephrine (E) in the peripheral and cavernous blood of healthy men during penile flaccidity and in different phases of erection.
MATERIALS AND METHODS: Blood samples were drawn simultaneously from the corpus cavernosum (CC) and the cubital vein (P) in 53 healthy volunteers with normal erectile function, in four different functional states of the cavernous erectile tissue (flaccidity = 1, tumescence = 2, rigidity = 3, detumescence = 4). Penile erections were induced by audiovisual and tactile stimulation and the plasma concentrations of NE and E were determined by means of a radioimmunoassay (RIA).
RESULTS: A significant (p <0.001) reduction of NE in CC plasma was found from flaccidity (362 + or - 173 pg./ml.) to rigidity (248 + or - 122 pg./ml.), followed by an increase in the detumescence phase (336 + or - 199 pg./ml.), (p <0.001). In contrast, changes in NE levels in the peripheral plasma were less pronounced from 1P (202 + or - 102 pg./ml.) to 3P (229 + or - 118 pg./ml.), (p = 0.006) and from 3P to 4P (222 + or - 127 pg./ml.), respectively (p = 0.370). The most pronounced increase in cavernous E levels were observed from flaccidity (47 + or - 41 pg. /ml.) to tumescence (130 + or - 106 pg./ml.) (p <0.001). Cavernous E levels dropped significantly from 113 + or - 67 pg./ml. during rigidity to 76 + or - 57 pg./ml. + or - during detumescence (p <0.001). The course of peripheral plasma levels of E was similar to that in the cavernous blood. Mean peripheral E level was 69 + or - 55 pg./ml. in the state of penile flaccidity, reaching 98 + or - 78 pg./ml. in tumescence and 82 + or - 64 pg./ml. in rigidity (p <0.001), respectively, and finally decreasing to 62 + or - 46 pg./ml. in detumescence.
CONCLUSION: Penile erection, based on the relaxation of cavernous and arterial smooth muscle, is accompanied by a significant reduction of NE in cavernous blood, while E levels rose in peripheral and cavernous blood during developing erection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893646

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  Cardiovascular risks of sexual activity.

Authors:  A M Safi; R A Stein
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

2.  The effects of age and streptozotocin diabetes on the sympathetic innervation in the rat penis.

Authors:  J F B Morrison; D J Pallot; R Sheen; S Dhanasekaran; E P K Mensah-Brown
Journal:  Mol Cell Biochem       Date:  2006-08-31       Impact factor: 3.396

Review 3.  Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action.

Authors:  Ibrahim A Abdel-Hamid
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Systemic and cavernous plasma levels of vasopressin in healthy males during different functional conditions of the penis.

Authors:  Armin J Becker; Stefan Uckert; Björn O Ness; Christian G Stief; Friedemann Scheller; Wolfram H Knapp; Udo Jonas
Journal:  Urol Res       Date:  2003-03-01

5.  Latent class analysis to evaluate performance of plasma cortisol, plasma catecholamines, and SHSQ-25 for early recognition of suboptimal health status.

Authors:  Yu-Xiang Yan; Li-Juan Wu; Huan-Bo Xiao; Shuo Wang; Jing Dong; Wei Wang
Journal:  EPMA J       Date:  2018-08-01       Impact factor: 6.543

6.  Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target.

Authors:  Silvia Giatti; Alessandro Di Domizio; Silvia Diviccaro; Eva Falvo; Donatella Caruso; Alessandro Contini; Roberto Cosimo Melcangi
Journal:  J Med Chem       Date:  2021-04-12       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.